Flufenacet

Flufenacet

SCHEMBL6062274

CC(C)N(C(=O)COc1nnc(C(F)(F)F)s1)c1ccc(F)cc1.COc1cc(OC)nc(NC(=O)NS(=O)(=O)c2c(-c3nnn(C)n3)cnn2C)n1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.39
CDK1 P06493 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Flufenacet SCHEMBL19463690 0.81 GAA (0.44) GAACDK1
Trifloxysulfuron SCHEMBL6061945 0.79 GAA (0.42) GAACDK1
SCHEMBL55386 0.78 GAA (0.49) GAACDK1
Foramsulfuron SCHEMBL6061956 0.76 CDK1 (0.61) GAACDK1
Flufenacet SCHEMBL6061984 0.76 GAA (0.39) GAACDK1
SCHEMBL9878291 0.73 GAA (0.44) GAACDK1
SCHEMBL28087093 0.73 GAA (0.43) GAACDK1
Flufenacet SCHEMBL116467 0.72 MLYCD (0.34)
Flufenacet SCHEMBL4897219 0.72 MLYCD (0.34)
Flufenacet SCHEMBL7205592 0.71 MLYCD (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060009359-A1 Selective heteroaryloxy-acetamide-based herbicides FEUCHT DIETER 2006-01-12 US disclosed
US-6967188-B2 Selective heteroaryloxy- acetamides-based herbicides BAYER CROPSCIENCE AG (DE) 2005-11-22 US disclosed
US-20040102321-A1 Selective heteroaryloxy- acetamides-based herbicides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2004-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060009359-A1 Selective heteroaryloxy-acetamide-based herbicides AADAC, HACL2, HDHD5 GAA 82/4885CDK1 4023/4885
US-20040102321-A1 Selective heteroaryloxy- acetamides-based herbicides AADAC, HACL2, HDHD5 GAA 91/4885CDK1 3875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.